The mouse has rapidly become the mammalian model organism of choice in ageing research due to its relatively short lifespan, the proximity of its genome and physiology to humans, and most importantly due to its genetic pliability and the availability of mutant strains. Mouse models have provided great insights into the ageing process, which in its broadest sense is the progressive decline of body functions over time. In this mini-review, we briefly cover the historical views on the link between ageing and metabolic rate, highlight genetically modified transgenic mouse models of extended lifespan, discuss endocrine pathways linked to senescence and ageing, and then examine pathways by which caloric restriction is postulated to result in longevity.

Keywords:
Genetic mouse models of extended lifespan, Laboratory mice, Growth hormone signalling, Longevity pathways, Ageing, Comparative biology, Insulin, Insulin-like growth factor-1, Energy metabolism, Caloric restriction
1.
Demetrius L: Aging in mouse and human systems: a comparative study. Ann NY Acad Sci 2006;1067:66-82.
2.
Mitchell SJ, Madrigal-Matute J, Scheibye-Knudsen M, Fang E, Aon M, González-Reyes JA, Cortassa S, Kaushik S, Gonzalez-Freire M, Patel B, Wahl D, Ali A, Calvo-Rubio M, Burón MI, Guiterrez V, Ward TM, Palacios HH, Cai H, Frederick DW, Hine C, Broeskamp F, Habering L, Dawson J, Beasley TM, Wan J, Ikeno Y, Hubbard G, Becker KG, Zhang Y, Bohr VA, Longo DL, Navas P, Ferrucci L, Sinclair DA, Cohen P, Egan JM, Mitchell JR, Baur JA, Allison DB, Anson RM, Villalba JM, Madeo F, Cuervo AM, Pearson KJ, Ingram DK, Bernier M, de Cabo R: Effects of sex, strain, and energy intake on hallmarks of aging in mice. Cell Metab 2016;23:1093-1112.
3.
Nussey DH, Froy H, Lemaitre JF, Gaillard JM, Austad SN: Senescence in natural populations of animals: widespread evidence and its implications for bio-gerontology. Ageing Res Rev 2013;12:214-225.
4.
Phelan JP, Austad SN: Natural selection, dietary restriction, and extended longevity. Growth Dev Aging 1989;53:4-6.
5.
Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, Hart RW: Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci 1999;54:B492-B501.
6.
Harper JM: Wild-derived mouse stocks: an underappreciated tool for aging research. Age (Dordr) 2008;30:135-145.
7.
Miller RA, Austad S, Burke D, Chrisp C, Dysko R, Galecki A, Jackson A, Monnier V: Exotic mice as models for aging research: polemic and prospectus. Neurobiol Aging 1999;20:217-231.
8.
Austad SN: The comparative perspective and choice of animal models in aging research. Aging Clin Exp Res 1993;5:259-267.
9.
Macías-Núñez JF, Ribera Casado JM, de la Fuente del Rey M, Barja Quiroga G, Tresguerres JAF, Ariznavarreta C, López-Novoa JM: Biology of the aging process and its clinical consequence; in Macías-Núñez JF, Cameron JS, Oreopoulos DG (eds): The Aging Kidney in Health and Disease. New York, Springer, 2008, pp 55-91.
10.
Brayton CF, Treuting PM, Ward JM: Pathobiology of aging mice and GEM: background strains and experimental design. Vet Pathol 2012;49:85-105.
11.
Houtkooper RH, Argmann C, Houten SM, Cantó C, Jeninga EH, Andreux PA, Thomas C, Doenlen R, Schoonjans K, Auwerx J: The metabolic footprint of aging in mice. Sci Rep 2011;1:134.
12.
Speakman JR, Mitchell SE: Caloric restriction. Mol Aspects Med 2011;32:159-221.
13.
Bronikowski AM, Carter PA, Morgan TJ, Garland T, Ung N, Pugh TD, Weindruch R, Prolla TA: Lifelong voluntary exercise in the mouse prevents age-related alterations in gene expression in the heart. Physiol Genomics 2003;12:129-138.
14.
Mlekusch W, Tillian H, Lamprecht M, Trutnovsky H, Horejsi R, Reibnegger G: The effect of reduced physical activity on longevity of mice. Mech Ageing Dev 1996;88:159-168.
15.
Holloszy JO: Exercise increases average longevity of female rats despite increased food intake and no growth retardation. J Gerontol 1993;48:B97-B100.
16.
Rubner M: Das Problem der Lebensdauer und seine Beziehung zu Wachstum und Ernährung. Munich, Oldenberg, 1908.
17.
Speakman JR: Body size, energy metabolism and lifespan. J Exp Biol 2005;208:1717-1730.
18.
de Magalhães JP, Costa J, Church GM: An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts. J Gerontol A Biol Sci Med Sci 2007;62:149-160.
19.
Pearl R: The Rate of Living. London, University of London Press, 1928.
20.
Metchnikoff E: The Prolongation of Life: Optimistic Studies. New York/London, Putman's Sons, 1908, pp 161-183.
21.
Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
22.
Speakman JR, Talbot DA, Selman C, Snart S, McLaren JS, Redman P, Krol E, Jackson DM, Johnson MS, Brand MD: Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 2004;3:87-95.
23.
Duarte LC, Speakman JR: Low resting metabolic rate is associated with greater lifespan because of a confounding effect of body fatness. Age (Dordr) 2014;36:9731.
24.
Brand MD: Uncoupling to survive? The role of mitochondrial inefficiency in ageing Exp Gerontol 2000;35:811-820.
25.
Salin K, Auer SK, Rudolf AM, Anderson GJ, Cairns AG, Mullen W, Hartley RC, Selman C, Metcalfe NB: Individuals with higher metabolic rates have lower levels of reactive oxygen species in vivo. Biol Lett 2015;11:20150538.
26.
Rose G, Crocco P, De Rango F, Montesanto A, Passarino G: Further support to the uncoupling-to-survive theory: the genetic variation of human UCP genes is associated with longevity. PLoS One 2011;6:e29650.
27.
Hulbert AJ: Explaining longevity of different animals: is membrane fatty acid composition the missing link? Age (Dordr) 2008;30:89-97.
28.
Valencak TG, Ruf T: N-3 polyunsaturated fatty acids impair lifespan but have no role for metabolism. Aging Cell 2007;6:15-25.
29.
Valencak TG, Ruf T: Phospholipid composition and longevity: lessons from Ames dwarf mice. Age (Dordr) 2013;35:2303-2313.
30.
De Cabo R, Carmona-Gutierrez D, Bernier M, Hall MN, Madeo F: The search for antiaging interventions: from elixirs to fasting regimens. Cell 2014;157:1515-1528.
31.
Strong R, Miller RA, Antebi A, Astle M, Bogue M, Denzel MS, Fernandez E, Flurkey K, Hamilton KL, Lamming DW, Javors MA, de Magalhaes JP, Martinez PA, McCord JM, Miller BF, Müller M, Nelson JF, Ndukum J, Rainger GE, Richardson A, Sabatini DM, Salmon AB, Simpkins JW, Steegenga WT, Nadon NL, Harrison DE: Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 2016;15:872-884.
32.
Bartke A, Sun LY, Longo V: Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol Rev 2013;93:571-598.
33.
Brown-Borg HM, Borg KE, Meliska CJ, Bartke A: Dwarf mice and the ageing process. Nature 1996;384:33.
34.
Bartke A: Growth hormone, insulin and aging: the benefits of endocrine defects. Exp Gerontol 2011;46:108-111.
35.
Bartke A: Single-gene mutations and healthy ageing in mammals. Philos Trans R Soc Lond B Biol Sci 2011;366:28-34.
36.
Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A: Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med (Maywood) 2001;226:552-558.
37.
Westbrook R, Bonkowski MS, Strader AD, Bartke A: Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice. J Gerontol A Biol Sci Med Sci 2009;64:443-451.
38.
Selman C, Withers DJ: Mammalian models of extended healthy lifespan. Philos Trans R Soc Lond B Biol Sci 2011;366:99-107.
39.
Selman C, McLaren JS, Collins AR, Duthie GG, Speakman JR: The impact of experimentally elevated energy expenditure on oxidative stress and lifespan in the short-tailed field vole Microtus agrestis. Proc Biol Sci 2008; 275:1907-1916.
40.
Bartke A: Pleiotropic effects of growth hormone signaling in aging. Trends Endocrinol Metab 2011;22:437-442.
41.
Barzilai N, Huffman DM, Muzumdar RH, Bartke A: The critical role of metabolic pathways in aging. Diabetes 2012;61:1315-1322.
42.
Weindruch R, Walford RL, Fligiel S, Guthrie D: The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr 1986;116:641-654.
43.
Mitchell SE, Delville C, Konstantopedos P, Derous D, Green CL, Chen L, Han JDJ, Wang Y, Promislow DEL, Douglas A, Lusseau D, Speakman JR: The effects of graded levels of calorie restriction: III. Impact of short term calorie and protein restriction on mean daily body temperature and torpor use in the C57BL/6 mouse. Oncotarget 2015;6:18314-18337.
44.
Masoro EJ: Overview of caloric restriction and ageing. Mech Ageing Dev 2005;126:913-922.
45.
Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, Cervera P, Le Bouc Y: IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-187.
46.
Russell SJ, Kahn CR: Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007;8:681-691.
47.
Caldeira Da Silva CC, Cerqueira FM, Barbosa LF, Medeiros MHG, Kowaltowski AJ: Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell 2008;7:552-560.
48.
Chandel NS, Jasper H, Ho TT, Passegué E: Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing. Nat Cell Biol 2016;18:823-832.
49.
Mouchiroud L, Molin L, Dallière N, Solari F: Life span extension by resveratrol, rapamycin, and metformin: the promise of dietary restriction mimetics for an healthy aging. Biofactors 2010;36:377-382.
50.
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer KG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-342.
51.
Miller RA, Harrison DE, Astle CM, Baur JA, Rodriguez Boyd A, De Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R: Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 2011;66:191-201.
52.
Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, Javors MA, Xinna L, Nadon NL, Nelson JF, Pletcher S, Salmon AB, Sharp ZD, Van Roekel S, Winkleman L, Strong R: Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 2014;13:468-477.
53.
Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R: Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8:157-168.
54.
Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM: AMPK and PPARdelta agonists are exercise mimetics. Cell 2008;134:405-415.
55.
Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ: Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 2014;16:1165-1173.
56.
Kapahi P, Chen D, Rogers AN, Katewa SD, Li PWL, Thomas EL, Kockel L: With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010;11:453-465.
57.
Kirkwood TB, Shanley DP: Food restriction, evolution and ageing. Mech Ageing Dev 2005;126:1011-1016.
58.
Johnston SL, Grune T, Bell LM, Murray SJ, Souter DM, Erwin SS, Yearsley JM, Gordon IJ, Illius AW, Kyriazakis I, Speakman JR: Having it all: historical energy intakes do not generate the anticipated trade-offs in fecundity. Proc Biol Sci 2006;273:1369-1374.
59.
Mitchell SE, Delville C, Konstantopedos P, Hurst J, Derous D, Green C, Chen L, Han JJD, Wang Y, Promislow DE, Lusseau D, Douglas A, Speakman JR: The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL/6 mice. Oncotarget 2015;6:23213-23237.
60.
Promislow DEL, Fedorka KM, Burger JMS: Evolutionary biology of aging; in: Handbook of the Biology of Aging, ed 6. San Diego, Elsevier, 2005, pp 217-242.
61.
Brioche T, Kireev RA, Cuesta S, Gratas-Delamarche A, Tresguerres JA, Gomez-Cabrera MC, Vina J: Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses. J Gerontol A Biol Sci Med Sci 2014;69:1186-1198.
62.
Richardson A, Austad SN, Ikeno Y, Unnikrishnan A, McCarter RJ: Significant life extension by ten percent dietary restriction. Ann NY Acad Sci 2016;1363:11-17.
63.
Ladiges W, Van Remmen H, Strong R, Ikeno Y, Treuting P, Rabinovitch P, Richardson A: Lifespan extension in genetically modified mice. Aging Cell 2009;8:346-352.
64.
Austad SN, Fischer KE: Mammalian aging, metabolism, and ecology: evidence from the bats and marsupials. J Gerontol 1991;46:B47-B53.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.